{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T16:44:36Z","timestamp":1783529076494,"version":"3.55.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-025-05162-0","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T14:15:03Z","timestamp":1765289703000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Misdiagnosis of 99mTc-PYP-positive Danon disease as ATTR-CA: a case report and molecular imaging pitfalls"],"prefix":"10.1186","volume":"25","author":[{"given":"Liang-jun","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu-zhen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-lin","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu-jing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,9]]},"reference":[{"issue":"6","key":"5162_CR1","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.jcmg.2020.08.027","volume":"14","author":"TJ Poterucha","year":"2021","unstructured":"Poterucha TJ, Elias P, Bokhari S, Einstein AJ, DeLuca A, Kinkhabwala M, Johnson LL, Flaherty KR, Saith SE, Griffin JM, et al. Diagnosing transthyretin cardiac amyloidosis by technetium Tc 99m pyrophosphate: A test in evolution. JACC Cardiovasc Imaging. 2021;14(6):1221\u201331.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"2","key":"5162_CR2","doi-asserted-by":"publisher","first-page":"e221082","DOI":"10.1148\/radiol.221082","volume":"306","author":"YM Khor","year":"2023","unstructured":"Khor YM, Cuddy SAM, Singh V, Falk RH, Di Carli MF, Dorbala S. (99m)Tc Bone-Avid tracer cardiac scintigraphy: role in noninvasive diagnosis of transthyretin cardiac amyloidosis. Radiology. 2023;306(2):e221082.","journal-title":"Radiology"},{"issue":"37","key":"5162_CR3","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","volume":"44","author":"E Arbelo","year":"2023","unstructured":"Arbelo E, Protonotarios A, Gimeno JR, Arbustini E, Barriales-Villa R, Basso C, et al. 2023 ESC guidelines for the management of cardiomyopathies. Eur Heart J. 2023;44(37):3503\u2013626.","journal-title":"Eur Heart J"},{"key":"5162_CR4","doi-asserted-by":"crossref","unstructured":"Sugie K, Nishino I. History and perspective of LAMP-2 deficiency (Danon Disease). Biomolecules. 2024;14(10):1272-81.","DOI":"10.3390\/biom14101272"},{"issue":"12","key":"5162_CR5","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1001\/jama.2009.371","volume":"301","author":"BJ Maron","year":"2009","unstructured":"Maron BJ, Roberts WC, Arad M, Haas TS, Spirito P, Wright GB, Almquist AK, Baffa JM, Saul JP, Ho CY, et al. Clinical outcome and phenotypic expression in LAMP2 cardiomyopathy. JAMA. 2009;301(12):1253\u20139.","journal-title":"JAMA"},{"issue":"2 Pt 1","key":"5162_CR6","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.jcmg.2017.06.020","volume":"11","author":"BW Sperry","year":"2018","unstructured":"Sperry BW, Vranian MN, Tower-Rader A, Hachamovitch R, Hanna M, Brunken R, et al. Regional variation in technetium pyrophosphate uptake in transthyretin cardiac amyloidosis and impact on mortality. JACC Cardiovasc Imaging. 2018;11(2 Pt 1):234\u201342.","journal-title":"JACC Cardiovasc Imaging"},{"key":"5162_CR7","doi-asserted-by":"crossref","unstructured":"Holcman K, Chmura \u0141, Rubi\u015b P, Stepie\u0144 A, Graczyk K, Kostkiewicz M. Glu112Lys: a rare pathogenic transthyretin gene variant associated with negative scintigraphy findings. Pol Archives Intern Med. 2025;135(2):16903-5.","DOI":"10.20452\/pamw.16903"},{"issue":"4","key":"5162_CR8","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1007\/s12350-022-03149-4","volume":"30","author":"T Wollenweber","year":"2023","unstructured":"Wollenweber T, Rettl R, Kretschmer-Chott E, Rasul S, Kulterer OC, Kluge K, et al. Cardiac DPD-uptake time dependency in ATTR patients verified by quantitative SPECT\/CT and semiquantitative planar parameters. J Nucl Cardiol. 2023;30(4):1363\u201371.","journal-title":"J Nucl Cardiol"},{"issue":"6","key":"5162_CR9","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/j.jcmg.2020.03.020","volume":"13","author":"PR Scully","year":"2020","unstructured":"Scully PR, Morris E, Patel KP, Treibel TA, Burniston M, Klotz E, Newton JD, Sabharwal N, Kelion A, Manisty C, et al. DPD quantification in cardiac amyloidosis: A novel imaging biomarker. JACC Cardiovasc Imaging. 2020;13(6):1353\u201363.","journal-title":"JACC Cardiovasc Imaging"},{"key":"5162_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2025.133227","volume":"431","author":"K Holcman","year":"2025","unstructured":"Holcman K, Rubi\u015b P, \u0106miel B, Szot W, St\u0119pie\u0144-Wroniecka A, Graczyk K, et al. (99m)Tc]Tc-DPD SPECT\/CT evaluation of right and left ventricular involvement in cardiac transthyretin amyloidosis. Int J Cardiol. 2025;431:133227.","journal-title":"Int J Cardiol"},{"issue":"7","key":"5162_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/s11886-021-01518-y","volume":"23","author":"PG Ranganath","year":"2021","unstructured":"Ranganath PG, Tower-Rader A. Utility of cardiac magnetic resonance imaging in the diagnosis, prognosis, and treatment of infiltrative cardiomyopathies. Curr Cardiol Rep. 2021;23(7):87.","journal-title":"Curr Cardiol Rep"},{"key":"5162_CR12","doi-asserted-by":"crossref","unstructured":"Tziomalos G, Zegkos T, Baltagianni E, Bazmpani MA, Exadaktylou P, Parcharidou D, Gossios T, Doumas A, Karamitsos T, Vassilikos V et al. Transthyretin amyloid cardiomyopathy: current diagnostic approach and risk stratification with multimodality imaging. J Clin Med. 2025;14(6):2014-35.","DOI":"10.3390\/jcm14062014"},{"issue":"4","key":"5162_CR13","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.jaccao.2022.08.007","volume":"4","author":"A Cipriani","year":"2022","unstructured":"Cipriani A, De Michieli L, Porcari A, Licchelli L, Sinigiani G, Tini G, Zampieri M, Sessarego E, Argir\u00f2 A, Fumagalli C, et al. Low QRS voltages in cardiac amyloidosis: clinical correlates and prognostic value. JACC CardioOncology. 2022;4(4):458\u201370.","journal-title":"JACC CardioOncology"},{"key":"5162_CR14","doi-asserted-by":"crossref","unstructured":"Tsch\u00f6pe C, Elsanhoury A, Kristen AV. Transthyretin amyloid Cardiomyopathy-2025 update: current diagnostic approaches and emerging therapeutic options. J Clin Med. 2025;14(13):4785-4805.","DOI":"10.3390\/jcm14134785"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-05162-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-025-05162-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-05162-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T14:15:05Z","timestamp":1765289705000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-025-05162-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,9]]},"references-count":14,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5162"],"URL":"https:\/\/doi.org\/10.1186\/s12872-025-05162-0","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,9]]},"assertion":[{"value":"12 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This is a prospective study. Consent forms were obtained from all patients. The study followed the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from all participants\/patients for the publication of their personal and clinical details, as well as any identifying images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"861"}}